Detection of Tumor Cells in Blood Stem Cells of Cancer Patients
Author Information
Author(s): Kasahara T, Hara N, Bilim V, Tomita Y, Saito K, Obara K, Takahashi K
Primary Institution: Niigata University Graduate School of Medical and Dental Sciences
Hypothesis
Does induction chemotherapy reduce the presence of alphafetoprotein-bearing tumor cells in blood stem cell harvests from advanced germ cell tumor patients?
Conclusion
After three cycles of chemotherapy, alphafetoprotein mRNA was not detected in most patients' blood stem cell samples, suggesting a potential reduction in tumor cell contamination.
Supporting Evidence
- Alphafetoprotein mRNA was detected in blood stem cell samples after the first or second cycle of chemotherapy.
- In 3 of 4 samples, alphafetoprotein mRNA was not detected after the third cycle of chemotherapy.
- The study suggests that harvesting blood stem cells after at least three cycles of chemotherapy may reduce the risk of tumor cell contamination.
Takeaway
The study looked at whether chemotherapy helps clean cancer cells from blood stem cells in patients. After a lot of treatment, fewer cancer cells were found.
Methodology
Cryopreserved peripheral blood stem cell samples were analyzed using nested reverse transcription polymerase chain reaction to detect alphafetoprotein mRNA.
Limitations
The study had a small sample size and did not definitively determine the impact of tumor cell contamination on disease relapse.
Participant Demographics
Patients with advanced stage II/III AFP producing germ cell tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website